CUSIP No. 019770106 | 13G | Page 1 0 of 10 Pages |
Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock of Allogene Therapeutics, Inc., a Delaware corporation, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which, taken together, shall constitute one and the same instrument.
Dated: February 13, 2019
/s/ Arie Belldegrun |
Arie Belldegrun, M.D. |
Belldegrun Family Trust | ||
By: | /s/ Arie Belldegrun | |
Name: | Arie Belldegrun, Trustee |
Bellco Capital LLC | ||
By: | /s/ Arie Belldegrun | |
Name: | Arie Belldegrun, Manager |
VVAG Special Fund LLC By: VVAG LLC, its Manager | ||
By: | /s/ Arie Belldegrun | |
Name: | Arie Belldegrun, Senior Managing Director | |
Vida Ventures LLC By: VV Manager LLC, its Manger | ||
By: | /s/ Arie Belldegrun | |
Name: | Arie Belldegrun, Senior Managing Director |